Alteplase and disseminated intravascular coagulation Patient Reports February 12, 2012



Alteplase Side Effects Report #5273099-0
Alteplase side effect was reported by a Consumer or non-health professional from JAPAN on Mar 08, 2007. Female patient, 69 years of age, was diagnosed with cerebral infarction and was treated with Alteplase. After drug was administered, patient experienced the following side effects: brain stem haemorrhage, disseminated intravascular coagulation. Alteplase dosage: 28.8 MG, INTRAVENOUS. During the same period patient was treated with RADICUT. Patient was hospitalized. Patient recovered.

Alteplase Side Effects Report #5298295-8
Alteplase side effect was reported by a Health Professional from JAPAN on Apr 02, 2007. Female patient, 69 years of age, was diagnosed with cerebral infarction and was treated with Alteplase. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, brain stem haemorrhage, cerebral haemorrhage, disseminated intravascular coagulation. Alteplase dosage: 28.8 MG, SINGLE; INTRAVENOUS. During the same period patient was treated with RADICUT, HAEMORRHAGE. Patient was hospitalized. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Alteplase